AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 50 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $562,000 | -47.1% | 669,449 | -30.1% | 0.03% | -58.2% |
Q3 2014 | $1,063,000 | -51.6% | 958,026 | -20.2% | 0.08% | -51.8% |
Q2 2014 | $2,197,000 | -48.6% | 1,200,800 | -58.0% | 0.16% | -7.3% |
Q1 2014 | $4,274,000 | +63.4% | 2,858,348 | +100.0% | 0.18% | -27.5% |
Q4 2013 | $2,615,000 | -63.8% | 1,429,174 | -59.3% | 0.24% | -67.8% |
Q3 2013 | $7,229,000 | -17.6% | 3,509,205 | 0.0% | 0.76% | -26.8% |
Q2 2013 | $8,773,000 | – | 3,509,205 | – | 1.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,866,483 | $4,285,000 | 2.24% |
Sarissa Capital Management LP | 2,570,759 | $3,843,000 | 1.32% |
Greylock XI GP Limited Partnership | 584,004 | $876,000 | 0.56% |
Deer VI & Co. LLC | 675,242 | $1,013,000 | 0.44% |
DAFNA Capital Management LLC | 261,507 | $391,000 | 0.34% |
Palo Alto Investors LP | 2,858,348 | $4,274,000 | 0.18% |
Baupost Group | 3,829,350 | $5,725,000 | 0.14% |
SABBY MANAGEMENT, LLC | 573,416 | $857,000 | 0.05% |
Granahan Investment Management | 676,451 | $1,011,000 | 0.03% |
TFS CAPITAL LLC | 176,633 | $264,000 | 0.02% |